APA (7th ed.) Citation

Noll, E. M., Stenzinger, A., Muckenhuber, A., Eils, R., Giese, N., Hackert, T., . . . Weichert, W. (2016). CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nature medicine, 22(3), . https://doi.org/10.1038/nm.4038

Chicago Style (17th ed.) Citation

Noll, Elisa Marie, et al. "CYP3A5 Mediates Basal and Acquired Therapy Resistance in Different Subtypes of Pancreatic Ductal Adenocarcinoma." Nature Medicine 22, no. 3 (2016). https://doi.org/10.1038/nm.4038.

MLA (9th ed.) Citation

Noll, Elisa Marie, et al. "CYP3A5 Mediates Basal and Acquired Therapy Resistance in Different Subtypes of Pancreatic Ductal Adenocarcinoma." Nature Medicine, vol. 22, no. 3, 2016, https://doi.org/10.1038/nm.4038.